- Report
- October 2024
- 188 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- August 2024
- 144 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- August 2024
- 185 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- August 2024
- 132 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- July 2024
- 157 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- August 2024
- 120 Pages
North America
From €3797EUR$4,000USD£3,203GBP
- Report
- May 2024
- 339 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 664 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- January 2025
- 159 Pages
Global
From €4414EUR$4,650USD£3,724GBP
- Report
- March 2025
- 190 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 181 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 199 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 179 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- July 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2024
- 227 Pages
Global
From €4225EUR$4,450USD£3,563GBP
- Report
- February 2025
- 172 Pages
Global
From €2848EUR$3,000USD£2,402GBP
- Report
- April 2024
- 407 Pages
Global
From €3418EUR$3,600USD£2,883GBP
- Report
- July 2024
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- February 2025
North America
From €4652EUR$4,900USD£3,924GBP

The Clinical Microbiology market within the In Vitro Diagnostics (IVD) sector is a rapidly growing field. It is focused on the development and production of diagnostic tests and instruments used to detect and identify microorganisms, such as bacteria, viruses, fungi, and parasites. These tests are used to diagnose and monitor infectious diseases, as well as to detect and monitor antibiotic resistance. Clinical Microbiology tests are used in a variety of settings, including hospitals, laboratories, and point-of-care settings.
The Clinical Microbiology market is driven by the increasing prevalence of infectious diseases, the emergence of new pathogens, and the need for rapid and accurate diagnosis. Additionally, the increasing demand for personalized medicine and the development of new technologies are expected to drive the market in the future.
Some of the major companies in the Clinical Microbiology market include Abbott Laboratories, Becton Dickinson, bioMérieux, Cepheid, Danaher Corporation, Hologic, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more